Calithera Biosciences, Inc. (CALA)

Calithera Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2022	2021	2020	2019	2018
Market Capitalization	0	16	49	338	270	147
Market Cap Growth	-68.18%	-66.88%	-85.46%	25.08%	84.05%	-46.65%
Enterprise Value	-24	-8	-7	237	218	96
PE Ratio	-	-0.86	-0.30	-3.82	-3.13	-2.85
PS Ratio	-	-	5.04	-	-	6.60
PB Ratio	0.00	0.80	-0.10	-0.90	-0.94	-0.75
P/FCF Ratio	-0.36	-0.37	-0.74	-4.00	-3.43	-2.26
P/OCF Ratio	-0.36	-0.37	-0.74	-4.01	-3.43	-2.26
EV/Sales Ratio	-	-	-0.76	-	-	4.30
EV/EBITDA Ratio	0.18	0.17	0.54	-2.60	-2.35	-1.67
EV/EBIT Ratio	0.18	0.17	0.53	-2.59	-2.33	-1.66
EV/FCF Ratio	0.18	0.17	0.11	-2.81	-2.77	-1.47
Debt / Equity Ratio	0.08	0.08	-0.01	-0.02	-0.03	0
Debt / EBITDA Ratio	-0.04	-0.04	-0.22	-0.07	-0.09	-
Debt / FCF Ratio	-0.04	-0.04	-0.05	-0.08	-0.10	-
Quick Ratio	3.44	3.44	4.25	6.34	8.04	9.28
Current Ratio	3.60	3.60	4.39	6.45	8.14	9.42
Asset Turnover	0	0	0.15	0	0	0.16
Interest Coverage	0.35	2.02	0	0	0	0
Return on Equity (ROE)	2.07%	-92.52%	33.65%	23.53%	30.18%	26.24%
Return on Assets (ROA)	1.47%	-65.79%	-255.32%	-70.49%	-51.16%	-36.06%
Return on Capital (ROIC)	-190.74%	-190.74%	23.64%	24.73%	33.43%	29.20%
Earnings Yield	692.87%	-115.93%	-336.52%	-26.20%	-31.96%	-35.07%
FCF Yield	-71817.23%	-268.78%	-135.24%	-24.97%	-29.15%	-44.32%
Buyback Yield / Dilution	-33.08%	-35.17%	-7.32%	-45.46%	-29.25%	-11.09%
Total Shareholder Return	-33.08%	-35.17%	-7.32%	-45.46%	-29.25%	-11.09%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.